Clincosm LogoSign in Get a demo

Malignant Melanoma

Showing NaN - NaN of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in United States (STK-012,

Recruiting
  • Advanced Solid Tumor
  • +10 more
  • Boston, Massachusetts
  • +8 more
Jan 2, 2023

Malignant Melanoma, NSCLC, Brain Tumors, Primary Trial in United States (PF-07284890, Binimetinib, Midazolam)

Recruiting
  • Malignant Melanoma
  • +4 more
  • Duarte, California
  • +71 more
Dec 29, 2022

GI Complications in Cancer Immunotherapy Patients

Recruiting
  • Malignant Melanoma
    • Boston, Massachusetts
      Massachusetts General Hospital
    Apr 4, 2022

    IL-2 "SELECT" Tissue Collection Protocol in Advanced Melanoma

    Completed
    • Malignant Melanoma
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Jan 13, 2021

    Malignant Melanoma, Medullary Thyroid Cancer, Glioblastoma Trial in United States (Rovalpituzumab tesirine, Dexamethasone)

    Terminated
    Has Results
    • Malignant Melanoma
    • +7 more
    • Gilbert, Arizona
    • +29 more
    Sep 21, 2020

    Malignant Melanoma Trial in United States (Atezolizumab, Cobimetinib, Vemurafenib)

    Completed
    • Malignant Melanoma
    • Los Angeles, California
    • +7 more
    Jul 20, 2020

    Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (PF-05082566, rituximab)

    Completed
    Has Results
    • Lymphoma, Non-Hodgkin
    • +6 more
    • Duarte, California
    • +41 more
    Mar 4, 2020

    Malignant Melanoma Trial in Worldwide (ABI-007, Dacarbazine)

    Completed
    Has Results
    • Malignant Melanoma
    • Birmingham, Alabama
    • +111 more
    Oct 16, 2019

    Malignant Melanoma Trial in Boston, New York (IMC-20D7S (Cohort 1A), IMC-20D7S (Cohort 2A), IMC-20D7S (Cohort 3A))

    Completed
    Has Results
    • Malignant Melanoma
    • IMC-20D7S (Cohort 1A)
    • +6 more
    • Boston, Massachusetts
    • +1 more
    Mar 11, 2019

    Malignant Melanoma Trial in Worldwide (Ipilimumab)

    Terminated
    Has Results
    • Malignant Melanoma
    • Ipilimumab
    • Phoenix, Arizona
    • +31 more
    Jul 31, 2017

    Malignant Melanoma Trial in United States (Drug cocktail, RO5185426)

    Completed
    Has Results
    • Malignant Melanoma
    • Los Angeles, California
    • +4 more
    Jul 6, 2017

    Malignant Melanoma Trial in Australia, United States (vemurafenib)

    Completed
    Has Results
    • Malignant Melanoma
    • Los Angeles, California
    • +14 more
    Jun 26, 2017

    Malignant Melanoma Trial in Boston (INKT, GM-CSF)

    Completed
    • Malignant Melanoma
    • Boston, Massachusetts
    • +1 more
    Jun 7, 2017

    Melanoma, Malignant Melanoma Trial in Boston (LBH589)

    Completed
    • Melanoma
    • Malignant Melanoma
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Mar 27, 2017

    Malignant Melanoma Trial in Canada, United States (Nivolumab, Ipilimumab)

    No longer available
    • Malignant Melanoma
    • Gilbert, Arizona
    • +65 more
    Feb 6, 2017

    Malignant Melanoma Trial in Worldwide (vemurafenib)

    Terminated
    Has Results
    • Malignant Melanoma
    • Los Angeles, California
    • +25 more
    Aug 25, 2016

    Malignant Melanoma Trial in Worldwide (Vemurafenib, Dacarbazine)

    Completed
    Has Results
    • Malignant Melanoma
    • Birmingham, Alabama
    • +110 more
    Aug 19, 2016

    Malignant Melanoma Trial in United States (RO5185426)

    Completed
    Has Results
    • Malignant Melanoma
    • Tucson, Arizona
    • +27 more
    Jul 12, 2016

    Malignant Melanoma Trial in Worldwide (Vemurafenib)

    Completed
    Has Results
    • Malignant Melanoma
    • Los Angeles, California
    • +32 more
    Jun 20, 2016

    Melanoma, Malignant Melanoma Trial in Israel, United States (CT-011)

    Completed
    • Melanoma
    • Malignant Melanoma
    • New Haven, Connecticut
    • +17 more
    Dec 16, 2015

    Malignant Melanoma Trial in Worldwide (HSPPC-96 or Oncophage)

    Completed
    • Malignant Melanoma
    • HSPPC-96 or Oncophage
    • Birmingham, Alabama
    • +76 more
    Sep 6, 2012

    Malignant Melanoma Trial in Worldwide (CancerVax vaccine (CANVAXIN))

    Unknown status
    • Malignant Melanoma
    • CancerVax vaccine (CANVAXIN)
    • Tucson, Arizona
    • +79 more
    Jun 23, 2005

    Malignant Melanoma Trial in Worldwide (CancerVax vaccine (CANVAXIN))

    Unknown status
    • Malignant Melanoma
    • CancerVax vaccine (CANVAXIN)
    • Tucson, Arizona
    • +76 more
    Jun 23, 2005